At the time of writing, Conmed Corp [CNMD] stock is trading at $70.00, up 0.98%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CNMD shares have lost -3.66% over the last week, with a monthly amount drifted -2.44%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Conmed Corp [NYSE: CNMD] stock has seen the most recent analyst activity on February 01, 2024, when Needham reiterated its Buy rating and also boosted its price target to $129 from $119. Previously, CL King started tracking the stock with Buy rating on May 22, 2023, and set its price target to $140. On March 27, 2023, upgrade upgraded it’s rating to Overweight but maintained its price target of $124 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $96 on March 21, 2023. Jefferies initiated its recommendation with a Hold and recommended $85 as its price target on October 12, 2022. In a note dated October 06, 2021, Needham upgraded an Buy rating on this stock but restated the target price of $150.
For the past year, the stock price of Conmed Corp fluctuated between $61.05 and $114.80. Currently, Wall Street analysts expect the stock to reach $97 within the next 12 months. Conmed Corp [NYSE: CNMD] shares were valued at $70.00 at the most recent close of the market. An investor can expect a potential return of 38.57% based on the average CNMD price forecast.
Analyzing the CNMD fundamentals
According to Conmed Corp [NYSE:CNMD], the company’s sales were 1.28B for trailing twelve months, which represents an 4.27% jump. Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.15 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 68.90 points at the first support level, and at 67.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 70.96, and for the 2nd resistance point, it is at 71.92.
Ratios To Look Out For
It is important to note that Conmed Corp [NYSE:CNMD] has a current ratio of 2.27. Further, the Quick Ratio stands at 1.06, while the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 1.68, the price to book ratio is 2.32 and price to earnings (TTM) ratio is 16.59.
Transactions by insiders
Recent insider trading involved Hartman Curt R, Officer, that happened on Nov 08 ’24 when 2849.0 shares were purchased. Officer, Peters Stanley W III completed a deal on Aug 27 ’24 to buy 2171.0 shares. Meanwhile, President AS and AET Peters Stanley W III sold 4000.0 shares on Jun 14 ’24.
